AI-generated summary
The authors randomly assigned 44 leukemic children with chemotherapy-induced oral mucositis to conventional symptomatic care alone or with photobiomodulation added. The test group showed significantly less pain by day 10 and lower mucositis grades by day 14 compared with controls, and no adverse events were reported.
- Participants
- 44
- Who or what was studied
- Leukemic children with chemotherapy-induced oral mucositis at a single hospital in Alexandria, Egypt
- Limits stated in the abstract
- The abstract reports a single-center trial in a small sample and does not state the light wavelength or dose used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.